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Introduction 
 
Post-translational modification (PTM) of a protein, which is a covalent modification of amino 
acid residues in a protein, is one of the most efficient biological mechanisms for expanding the 
genetic code and for regulating cellular physiology. Among proteins undergoing PTMs, 
histones play fundamental roles. Histones are highly alkaline proteins found in eukaryotic cell 
nuclei that package and order the DNA into structural unit called nucleosome. It contains 147 
base pairs of DNA, which are wrapped around a histone octamer that consists of two copies of 
the four core histones H2A, H2B, H3 and H4. Each core histone is composed of two structurally 
distinct regions, an N-terminal tail region, which is rich in positively-charged lysine and 
arginine residues and flexibly protrudes through the DNA superhelices, and a globular region, 
which forms nucleosome’s scaffold[1]. Among PTMs on histones, acetylation of lysine residues 
is a fundamental regulatory element for activating gene expression and epigenetics[2]. In cells, 
the acetylation level of histones is controlled by the balance of two enzymes, histone 
acetyltransferase (HAT) and histone deacetylase (HDAC). Small molecule inhibitors of HDAC 
(e.g., suberoylanilide hydroxamic acid, also known as vorinostat or Zolinza) are potential 
anticancer agents because promoting histone acetylation likely activates the transcription of a 
series of genes, including tumor suppressor genes (p53), which are often inactivated in cancer 
cells. HDAC inhibitors rely on HAT’s activity for their promotion of lysine acetylation, so an 
alternative strategy to bypass these enzymes is essential for treating cancer cells with low or no 
HAT activity. To date, however, there are no synthetic systems enabling HAT-independent and 
selective acetylation of histones.  
We previously developed two types of artificial catalyst systems named SynCAc (Figure 1) and 
DSH (Figure 2). SynCAc system is composed of an acetylation mediator (8DMAP) and an 
acetyl donor (3NMD-8R), both bind with DNA in the nucleosomes, enabling tail region-
selective lysine acetylation of recombinant nucleosomes (rNuc). DSH promotes lysine residue-
  
selective acetylation of histones in rNuc with acetyl-CoA, endogenous acetyl donor, when 
conjugated with different histone-binding ligands.  
 
It was, however, unknown whether 
recently identified lysine acylations other 
than acetylation, such as butyrylation and 
malonylation, are possible by our system. 
And it was necessary to develop a more 
powerful catalyst moiety in order to 
achieve in-cell acetylation reactions. Here 
I report tail-region selective acylations systems based on SynCAc, leading to induction of 
biochemical phenotypes by lysine malonylation, and development of a glutathione-resistant 
acetylation catalyst based on DSH for realization of in-cell acetylation reactions.  
 
Results and Discussion 
 
1. Development of histone tail-selective acylation systems based on SynCAc 
Given a distinct chemical nature of malonyl-lysine with a negatively charged carboxylate group, 
it has been proposed that lysine malonylaiton may result in significant changes in histone 
structure and functions. I, therefore, started with challenging this anionic modification. 
However, due to high reactivity of the original donor core, it was impossible to obtain this kind 
of malonyl donor. After intensive structural modifications, I found that a phenyl-ester type acyl 
donor has sufficient stability and enough reactivity under the physiological conditions. I 
successfully developed a variety of acyl donors (malonyl, glutaryl, butyryl and biotinyl) and 
realized histone-selective acylations of rNuc in the presence of HeLa cell cytoplasmic extracts 
(Figure 3). Preliminary LC-MS/MS quantification of the malonylation suggested that the 
acylation preferentially occurred in tail-regions. 
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Figure 2. Plausible mechanism 
of DSH-mediated acetylation reaction.
Figure 1. The components of SynCAc system.
  
 
Next, I examined biophysical properties of the malonylated nucleosomes. To evaluate 
internucleosomal interactions and the stability of nucleosomes, we performed a Mg2+-
dependent nucleosome self-association assay and a thermal shift assay, respectively[3]. As a 
result, malonylation by our system suppressed internucleosomal interactions significantly, and 
reduced the stability of the nucleosomes as well (Figure 4). To the best of knowledge, this is 
firstly-reported molecular functions of lysine malonylation of histone, and indicates a 
possibility that malonylation of histones promotes RNA transcription. This investigation is now 
ongoing. 
 
2. Development of glutathione-resistant acetylation catalyst 
Our previous investigations indicated that glutathione (GSH), a tripeptide comprised of L-
glutamic acid, L-cysteine and glycine, which is present in millimolar (1~10 mM) concentrations 
in animal cells, suppressed 
reactivity of catalyst DMAP-
SH, and it was considered as 
one of the major reasons that 
DSH system could not promote 
acetylation in living cells.	  A 
thiol group in GSH 
competitively attacks 
acetylpyridinium cation 
intermediate, preventing amide 
formation of lysine amine. I 
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Figure 4. Biophysical nature of the malonylated recombinant mononucleosome.
(a) Mg2+-dependent self-association assay of the malonylated recombinant
mononucleosome. (b) Thermal stability assay of the malonylated recombinant
mononucleosome. (error bar = SD, n = 3).
Figure 3. Selective introduction of acylations to recombinant nucleosome in the presence of  cytoplasmic extracts.
But: Butyryl, Bio: Biotinyl, Mal: Malonyl, Glu: Glutaryl.
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envisioned that by introduction of a formyl group to the catalyst, lysine amine was captured to 
form hemiaminal intermediate, leading to facile transfer of the activated acetyl group on the 
acetylpyridinium cation to the lysine in an intramolecular manner[4]. I investigated this 
possibility in a model study using a carbonic anhydrase (CA). In the absence of GSH, new 
catalyst PAQ-SH showed 
slightly lower reactivity than the 
original catalyst core (PDP-SH, 
Figure 5). In contrast, the new 
catalyst exhibited higher 
reactivity in the presence of 5 
mM GSH than the original one. 
Quantification analysis by LC-
MS/MS showed that around 
twice reactivity compared to PDP-SH was observed. This results suggest that PAQ-SH could 
be a superior catalyst motif than DMAP-SH for in-cell acetylation reactions. 
 
Conclusion	 	
	
  I developed histone-selective acylation systems by redesigning the acyl donors. Histone-
selective malonylation by the system efficiently suppressed internucleosomal interactions and 
reduced stability of nucleosome, which has a potential to promote transcription. A novel GSH-
resistant acetylation catalyst was also developed, which is an important step to achieve 
acetylation in living cells for regulation of cellular functions.	  
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Figure 5. Quantitative comparison between PDP-SH and PAQ-SH
in the absence or presence of GSH. (error bar = SD, n = 3).
CA
α-LysAc
Ponceau
GSH            0 mM 5 mM
Catalyst       - D A        - D       A
N
N
SH
O
NH
N
N
O
NH
SH
HO
PDP-SH (D) PAQ-SH (A)
Ligand for CA Ligand for CA
N
N
SH
NHHO
Lys
Hemiaminal structure
0
10
20
30
40
Yi
el
d 
by
 L
C
-M
S/
M
S
(%
)
